Other
Accounts Receivable, Chargebacks, Discounts And Fees
Moderna Accounts Receivable, Chargebacks, Discounts And Fees decreased by 30.4% to $126M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 173.7%, from -$171M to $126M.
Analysis
StatementBalance Sheet Statement
SectionOther
First reportedQ4 2022
Last reportedQ1 2026May 1, 2026
Metric ID:
other_accounts_receivable_chargebacks_discounts_and_feesHistorical Data
12 periods
| Q4 '22 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0 | -$479M | -$692M | -$285M | -$329M | -$1.17B | $340M | -$171M | $212M | $975M | $181M | $126M |
| QoQ Change | — | — | -44.5% | +58.8% | -15.4% | -255.0% | +129.1% | -150.3% | +224.0% | +359.9% | -81.4% | -30.4% |
| YoY Change | — | — | — | — | — | -143.8% | +149.1% | +40.0% | +164.4% | +183.5% | -46.8% | +173.7% |
Range-$1.17B – $975M
Avg YoY Growth+74.3%
Median YoY Growth+149.1%
Current Streak2 quarters decline
Frequently Asked Questions
- What is Moderna's accounts receivable, chargebacks, discounts and fees?
- Moderna (MRNA) reported accounts receivable, chargebacks, discounts and fees of $126M in Q1 2026.
- How has Moderna's accounts receivable, chargebacks, discounts and fees changed year-over-year?
- Moderna's accounts receivable, chargebacks, discounts and fees increased by 173.7% year-over-year, from -$171M to $126M.